While antigen-specific T cells may confer protection against SARS-CoV-2 virus [5–7], lymphopenia is associated with severe COVID-19 [8–10] and exhausted, senescent T cells and those expressing MKI67 [11, 12], a key proliferation marker, contribute to pathology [3, 13–15]. This evidence concerns the gene MKI67 and COVID-19.